Press What’s news at AbelsonTaylor Group
Select category
Top Innovations of 2024: AT Activate
Established in 2012, PM360 introduced the first-ever issue focused entirely on the pharma and healthcare marketing industry’s latest innovations. In 2024, AbelsonTaylor Group’s AT Activate was selected as a leader in Marketing Technology or Services. AT Activate, a full-service media agency, offers advanced end-to-end media strategy capabilities that make high-impact pharmaceutical advertising accessible to brands of all sizes. The solution is transforming the pharmaceutical advertising landscape for clients by leveraging data-driven insights, advanced technologies, and a dynamic approach to consumer, patient and healthcare professional (HCP) engagement. This strategy democratizes DTC high-cost TV buys with digital streaming for smaller brands or rare disease conditions with modest budgets. Read more at https://www.pm360online.com/pm360-2024-innovative-marketing-technology-or-services-at-activate/
Media Contact:
Recent Posts
As Bluesky continues to grow, opportunities abound for pharma brands
With over 30 million users, Bluesky Social is quickly gaining steam. Associate Director of Engagement Helen Hoye recently spoke to...
In the News Read more As Bluesky continues to grow, opportunities abound for pharma brandsBridging the gap in pharma marketing: Connecting pharma, HCPs, and patients for better communication
In MedAdNew’s bulletin, PharmaLive, Lynnette Hunter, EVP-Director of Client Services, offers a five-step approach to connecting pharma, HCPs and patients...
In the News Read more Bridging the gap in pharma marketing: Connecting pharma, HCPs, and patients for better communicationPrioritizing Mental Health
Prioritizing mental well-being can transform lives and careers. Read VP, Account Director Jeremy Vannatta’s story in the March 2025 mental...
In the News Read more Prioritizing Mental HealthConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.